Stage pT0 After Radical Prostatectomy With Previous Positive Biopsy Sets: A Multicenter Study

Journal of Urology

Volumn 183, Issue 3, 2010, Pages 958-962

  Bessède, Thomas ^a   Soulié, Michel ^b   Mottet, Nicolas ^c   Rebillard, Xavier ^d   Peyromaure, Michaël ^e   Ravery, Vincent ^f   Salomon, Laurent ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b CHU RANGUEIL   (France)

^c ESC Saint Etienne   (France)

^d Clinique Beausoleil   (France)

^e université Paris Cité   (France)

^f BICHAT HOSPITAL   (France)

Author keywords

biopsy; neoplasm regression; prostate; prostatectomy; prostatic neoplasms; spontaneous

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSURETHRAL RESECTION; TUMOR VOLUME;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 75849164990     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.11.016     Document Type: Article

References (24)

1. Greene F.L., Page D.L., Fleming I.D., et al. American Joint Committee on Cancer Manual for Staging Cancer. 6th ed. (2002), Springer, New York 337
2. Kollermann J., Feek U., Muller H., et al. Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. Eur Urol 38 (2000) 714
3. Herkommer K., Kuefer R., Gschwend J.E., et al. Pathological T0 prostate cancer without neoadjuvant therapy: clinical presentation and follow-up. Eur Urol 45 (2004) 36
4. Goldstein N.S., Begin L.R., Grody W.W., et al. Minimal or no cancer in radical prostatectomy specimens. Report of 13 cases of the "vanishing cancer phenomenon.". Am J Surg Pathol 19 (1995) 1002
5. Mazzucchelli R., Barbisan F., Tagliabracci A., et al. Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy. Virchows Arch 450 (2007) 371
6. Postma R., de Vries S.H., Roobol M.J., et al. Incidence and follow-up of patients with focal prostate carcinoma in 2 screening rounds after an interval of 4 years. Cancer 103 (2005) 708
7. MJ. Stamey T.A., Freiha F.S., and Redwine E. Morphometric and clinical studies on 68 consecutives radical prostatectomies. J Urol 139 (1988) 1235
8. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68
9. Corica F.A., and Bostwick D.G. Clinically unsuspected and undetected (clinical stage t0) prostate cancer diagnosed on random needle biopsy. Urology 53 (1999) 557
10. Schulman C.C., and Sassine A.M. Neoadjuvant hormonal deprivation before radical prostatectomy. Eur Urol 24 (1993) 450
11. Noguchi M., Noda S., Nakashima O., et al. No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer. Oncol Rep 9 (2002) 1075
12. Kollermann J., Hopfenmuller W., Caprano J., et al. Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysis. Eur Urol 45 (2004) 42
13. Prayer-Galetti T., Gardiman M., Sacco E., et al. Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer. Anal Quant Cytol Histol 29 (2007) 79
14. Bostwick D.G., and Bostwick K.C. 'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases. BJU Int 94 (2004) 57
15. Duffield A.S., and Epstein J.I. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the initial review of slides. Am J Surg Pathol 33 (2009) 120
16. Descazeaud A., Zerbib M., Flam T., et al. Can pT0 stage of prostate cancer be predicted before radical prostatectomy?. Eur Urol 50 (2006) 1248
17. Kommu S. A model to explain the 'vanishing' prostate-the curative biopsy theory. BJU Int 94 (2004) 939
18. DiGiuseppe J.A., Sauvageot J., and Epstein J.I. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol 21 (1997) 174
19. Suba E., Pfeiffer J., and Raab S. Patient identification error among prostate needle core biopsy specimens: are we ready for a DNA time-out?. J Urol 178 (2007) 1245
20. Cao D., Hafez M., Berg K., et al. Little or no residual prostate cancer at radical prostatectomy: vanishing cancer or switched specimen?. A microsatellite analysis of specimen identity. Am J Surg Pathol 29 (2005) 467
21. Trpkov K., Yuan G., Hay R., et al. No residual cancer on radical prostatectomy after positive 10-core biopsy: incidence, biopsy findings and DNA specimen identity analysis. Arch Pathol Lab Med 130 (2006) 811
22. Epstein J.I., Walsh P.C., Carmichael M., et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
23. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280 (1998) 969
24. Thwaini A., Anjum F., Kalubac J., et al. 'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases. BJU Int 94 (2004) 1145